Subdiagnostic psychopathology and self-reported anxiety across groups at baseline testing and 12-month follow-up
| Baseline testing | 12-month follow-up | ||||
|---|---|---|---|---|---|
| Outcome variable | Meth group (n=10) | Meth-cann group (n=10) | Control group (n=20) | Meth group (n=9) | Control group (n=10) |
| Sub-diagnostic symptom counts | |||||
| ADHD | 3.50 (6.19) | 4.30 (5.33) | 0.80 (1.64) | 3.56 (7.07) | 3.60 (8.33) |
| PTSD | 2.40 (4.53) | 1.70 (1.83) | 2.35 (4.39) | 1.67 (4.27) | 1.50 (2.76) |
| Externalising composite* | 4.80 (6.41) | 3.30 (4.08) | 0.60 (1.70) | 7.44 (5.70) | 1.90 (5.32) |
| MASC subtotals | |||||
| Physical symptoms | 12.60 (5.87) | 14.50 (7.28) | 11.73 (7.89) | 10.44 (10.25) | 10.20 (6.83) |
| Harm avoidance | 17.50 (5.38) | 18.70 (3.71) | 17.40 (5.10) | 19.44 (4.98) | 19.50 (3.27) |
| Social anxiety | 12.60 (4.55) | 14.00 (5.83) | 12.00 (7.51) | 8.11 (6.83) | 9.40 (2.22) |
| Separation/panic | 9.30 (5.23) | 10.90 (5.90) | 8.80 (5.57) | 9.00 (7.23) | 8.60 (4.03) |
| Total score | 50.80 (13.55) | 57.00 (19.77) | 48.80 (21.20) | 46.11 (24.64) | 46.40 (9.11) |
Means are presented with SDs in parentheses.
*Total symptoms of conduct disorder and oppositional defiant disorder.
ASHD, attention deficit/hyperactivity disorders; MASC, Multidimensional Anxiety Scale for Children; Meth-cann group, Methamphetamine and cannabis group; Meth group, Methamphetamine only group; PTSD, post-traumatic stress disorder.